PSEUDOEXFOLIATION GLAUCOMA
Clinical trials for PSEUDOEXFOLIATION GLAUCOMA explained in plain language.
Never miss a new study
Get alerted when new PSEUDOEXFOLIATION GLAUCOMA trials appear
Sign up with your email to follow new studies for PSEUDOEXFOLIATION GLAUCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could insulin eye drops save your sight? new trial launches
Disease control Not yet recruitingThis study tests whether insulin eye drops can protect the optic nerve in people with open-angle glaucoma. Researchers will give 90 participants either insulin drops or placebo daily for up to 12 months. The main goal is to check safety, but they will also measure vision changes …
Matched conditions: PSEUDOEXFOLIATION GLAUCOMA
Phase: PHASE1, PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Laser procedure could offer new hope for pseudoexfoliation glaucoma patients
Disease control Not yet recruitingThis study tests a non-invasive laser procedure called direct selective laser trabeculoplasty (DSLT) in 40 adults with pseudoexfoliation glaucoma. The goal is to see if the laser can safely lower eye pressure by at least 20% at 6 and 12 months. Participants will have their eye pr…
Matched conditions: PSEUDOEXFOLIATION GLAUCOMA
Phase: NA • Sponsor: Vance Thompson Vision • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Eye drop showdown: could common glaucoma meds save more than sight?
Knowledge-focused Not yet recruitingThis study looks at whether a common type of glaucoma eye drop (prostaglandin analogues) can protect the eye's nerve cells directly, not just by lowering eye pressure. Researchers will review medical records from 1500 adults with glaucoma over 3 years, comparing those on prostagl…
Matched conditions: PSEUDOEXFOLIATION GLAUCOMA
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC